Japanese study to evaluate the utility of eribulin dose and schedule in treatment for advanced breast cancer patients
Not Applicable
Completed
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000008491
- Lead Sponsor
- PO Advanced Clinical Reserch Organization
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
(1) infectious disease with fever (2) heart failure with clinically problem. significant interstitial pneumonia or pulmonary fibrosis by chest radiograph (3) pleural effusion, peritoneal effusion (4) presence of the active other malignancies (5) poorly controlled diabetes mellitus(6) brain metastasis with symptom (7) pregnant or nursing women (8) physician judged improper to entry this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method